CASE STUDY: Personal Experience as a Physician and Anti- MOG Positive Neuromyelitis Optica Patient (MOGAD)

Abstract

Neuromyelitis Optica (NMO) is a rare demyelinating disease, recently segregated from other demyelinating diseases due to its distinctive features that set it apart from multiple sclerosis (MS) and other central nervous system (CNS) disorders. Particularly, the presence of autoantibodies against myelin oligodendrocyte glycoprotein (MOG) has emerged as a specific subtype of NMO, known as MOGAD. This article presents a unique case in which a physician, with a specialization in neuroimmunology, personally experiences the challenges of delayed diagnosis and clinical management of this disease.